Spyre Therapeutics Breaks Higher On Positive Data From Ulcerative Colitis Drug

• Spyre Therapeutics stock is approaching key resistance levels. Why is SYRE stock breaking out?
Open original source
• Spyre Therapeutics stock is approaching key resistance levels. Why is SYRE stock breaking out?
Open original source